Magnemasks, page-133

How sly. They are loathe to use the word "magnetic" in their description, lest we discover their well kept secret.  


The Australian Patent Office formally has now formally granted two of company's patents that underpin its personalisation technology:

1. the patent titled "method and device for transdermal delivery of substances" was granted last year on 29 September 2016, which relates to the company's powered dermaportation technology;
2. the patent titled "a device, system, method, computer program and data signal for the control of a transdermal delivery device" was granted  a month ago on 10 August 2017, which relates to the personalisation technology that would allow the powered dermaporation device to be controlled in accordance with the company's unique personalisation algorithm.

These two inventions, and the acceptance of the patents,  are obviously critical to the successful commercialisation of company's personalisation technology.

On 22 August 2017, I emailed Glyn querying why BOTH patents no. 1 and no. 2 listed above, that had been granted, hadn't yet been announced by OBJ.  The following day, 23 August 2017, the company announced the granting of no. 2 (but omitted reference to no. 1.)

The specifications of No. 1 can be found here.  This, I think, is the OPTE "wand" device.